Establishes New Jersey Pancreatic Cancer Commission.
This bill creates the New Jersey Pancreatic Cancer Commission to study and address pancreatic cancer issues across the state. The commission will examine prevention, early detection, treatment, patient outcomes, and access to care, including reviewing incidence rates, screening practices, barriers to treatment, research efforts, and education needs. It will consist of 13 members appointed by the Governor, Senate President, Assembly Speaker, and minority leaders, including representatives from health departments, medical institutions, advocacy groups, and patient families. The commission will operate without compensation but receive expense reimbursement, and must submit a final report with findings and recommendations within 12 months of organization before expiring. The Department of Health will provide staff support, and the commission can access state employees as needed for its work.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 16, 2026
Last action Mar 16, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Mar 16, 2026
Introduced
Introduced, Referred to Assembly Health Committee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Shanique Speight
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about AJR 161
Scope: NJ
Hi! I can help you understand AJR 161. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline